GM

Glenn Mario Saldanha

Active Director Managing Director DIN 00050607 India's Richest · #99
DIN 00050607 First appointment Oct 1998 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 5 historical roles
Total affiliations 8 Since Oct 1998
Shareholding value •••• Premium profile

About Glenn Mario Saldanha

Data last updated:

Glenn Mario Saldanha is a Managing Director at Glenmark Pharmaceuticals Limited (since 1998), Director at Glenmark Consumer Care Limited (since 2025) and Director at Glenmark Healthcare Limited (since 2023). The companies operate in Pharma and Travel and Hospitality. The largest current company by reported revenue is Glenmark Pharmaceuticals Limited at ₹17,443 Cr (FY 2026). Earlier, Glenn Mario Saldanha was a Director at Alivus Life Sciences Limited (2018–2024) and Director at Talwalkars Better Value Fitness Limited (2009–2011) and 3 more.

Glenn Saldanha and family are #99 among India's richest people (2026), with wealth of ₹33,000 Cr.

DIN 00050607
Primary Designation Managing Director
Industry Pharma
First Appointment 12 Oct 1998
Oldest Company Age 48 yrs
Largest company Glenmark Pharmaceuticals Limited · ₹17,443 Cr (FY 2026)

Recognitions & Rankings

India's Richest People 2026 edition · Source: Hurun India
Rank#99
Wealth
₹33,000 Cr
Company
Glenmark Pharmaceuticals
2019 #125 2018 #102 2017 #77
India's Top Philanthropists 2022 edition · Source: Hurun India
Rank#66
Donation
₹12 Cr
Main cause
Skill Development
2021 #39 2020 #60

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Glenmark Pharmaceuticals Limited L24299MH1977PLC019982
Managing Director12 Oct 19981977₹17,443 Cr (FY 2026)Active
Glenmark Consumer Care Limited U21001MH2025PLC449082
Director23 May 20252025Active
Glenmark Healthcare Limited U21001MH2023PLC402796
Director12 May 20232023Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alivus Life Sciences Limited L74900PN2011PLC139963
Director06 Jul 20182011₹2,421 Cr (FY 2025)Active
Director09 Oct 20092003₹58.08 Cr (FY 2018)Under Liquidation
Glenmark Generics Limited U24110MH1994PLC081597
Director18 Dec 20071994Amalgamated
Gm Pharma Limited U24230MH1999PLC121475
Director26 Sep 20021999Amalgamated
Glenmark Access Limited U51900MH1996PLC102125
Director28 Sep 20011996Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Glenmark Pharmaceuticals Limited
Glenmark Generics Limited
Gm Pharma Limited
Glenmark Access Limited
Premium access

Shareholding and investment profile for Glenn Mario Saldanha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Glenn Mario Saldanha

Glenn Mario Saldanha currently holds 3 directorships: Glenmark Pharmaceuticals Limited (Managing Director, since 12 Oct 1998, revenue ₹17,443 Cr (FY 2026)); Glenmark Consumer Care Limited (Director, since 23 May 2025); Glenmark Healthcare Limited (Director, since 12 May 2023).

Glenn Mario Saldanha was first appointed on 12 Oct 1998 as Managing Director at Glenmark Pharmaceuticals Limited. The most recent appointment on record is 23 May 2025 at Glenmark Consumer Care Limited.

Glenn Mario Saldanha held 5 earlier board appointments: Alivus Life Sciences Limited (Director, 06 Jul 2018 to 07 Mar 2024); Talwalkars Better Value Fitness Limited (Director, 09 Oct 2009 to 22 Nov 2011); Glenmark Generics Limited (Director, from 18 Dec 2007); Gm Pharma Limited (Director, from 26 Sep 2002); Glenmark Access Limited (Director, from 28 Sep 2001).

The current boards of Glenn Mario Saldanha's companies include Anurag Mantri (Glenmark Pharmaceuticals Limited), Anurag Mantri (Glenmark Pharmaceuticals Limited), Blanche Saldanha Elizabeth (Glenmark Pharmaceuticals Limited), Cherylann Maria Pinto (Glenmark Pharmaceuticals Limited), Dipankar Bhattacharjee (Glenmark Pharmaceuticals Limited), Patricia Susan Andrews (Glenmark Pharmaceuticals Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available